<ul>
<li>3 只接近买入点的芯片股票</li>
</ul>
<p>根据 MarketBeat 的股票筛选工具，Onto Innovation、Nano Dimension、NVE 和 Clene 是今天值得关注的五只纳米技术股票。纳米技术股票是指那些开发、制造或商业化基于纳米材料、设备或工艺的产品和服务的公司的股票。对于投资者而言，这些股票通常被视为投机性增长投资，其价值依赖于长期的科学进展、商业化和监管批准。这些公司可以跨越医疗保健、电子、能源和先进材料等多个行业，由于技术和市场的不确定性，往往更加波动。这些公司在过去几天内的纳米技术股票中交易量最高。</p>
<p>获取 <strong>Onto Innovation</strong> 的提醒：</p>
<h2>Onto Innovation (ONTO)</h2>
<p>Onto Innovation Inc.从事光学计量过程控制工具的设计、开发、制造和支持。该公司提供光刻系统和过程控制分析软件。它还通过独立系统提供过程和产量管理解决方案，以及光学计量、宏观缺陷检测、包装光刻和透明及不透明薄膜测量的设备包装和测试设施。</p>
<p>阅读我们关于 ONTO 的最新研究报告</p>
<h2>Nano Dimension (NNDM)</h2>
<p>Nano Dimension Ltd.及其子公司在以色列和国际上从事增材制造解决方案。该公司提供 3D 打印机，包括 AME 系统，这是一种喷墨打印机，通过沉积专有的导电和绝缘物质来生产 Hi-PEDs，并集成原位电容器、天线、线圈、变压器和机电组件；微增材制造系统，一种数字光处理打印机（DLP），可实现生产级聚合物和复合材料零件；以及工业增材制造系统，利用专利箔系统制造陶瓷和金属零件。</p>
<p>阅读我们关于 NNDM 的最新研究报告</p>
<h2>NVE (NVEC)</h2>
<p>NVE Corporation 开发和销售使用自旋电子学的设备，这是一种依赖电子自旋来获取、存储和传输信息的纳米技术。该公司制造自旋电子产品，包括用于获取和传输数据的传感器和耦合器。</p>
<p>阅读我们关于 NVEC 的最新研究报告</p>
<h2>Clene (CLNN)</h2>
<p>Clene Inc.是一家临床阶段的制药公司，专注于新型清洁表面纳米技术（CSN）治疗药物的发现、开发和商业化。其主要药物候选者是 CNM-Au8，目前正在进行多项临床试验，包括一项已完成的第二阶段平台试验，以评估 CNM-Au8 在肌萎缩侧索硬化症（ALS）患者中的安全性和有效性；已完成的第二阶段概念验证临床试验，针对早期症状性 ALS 患者；已完成的两项开放标签研究者盲法第二阶段临床试验，研究大脑能量代谢物；已完成的第二阶段临床试验，治疗慢性视神经病变中的视觉通路缺陷以促进再髓鞘化；以及第二项第二阶段临床试验，治疗帕金森病患者。</p>
<p>阅读我们关于 CLNN 的最新研究报告</p>
<h2>了解更多</h2>
<ul>
<li>MarketBeat 在 2026 年 1 月的五大股票推荐</li>
<li>3 只内部人士正在买入而非抛售的股票</li>
<li>这 3 只被低估的 ETF 可能在 2026 年大幅上涨</li>
<li>NVIDIA 的下一轮上涨可能在 CES 上开始</li>
<li>MarketBeat 周报 – 01/05 - 01/09</li>
<li>华纳兄弟拒绝派拉蒙的报价——这对 WBD、NFLX、PSKY 的影响</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 到 Onto Innovation 吗？</h2>
<p>在你考虑 Onto Innovation 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即买入……而 Onto Innovation 并不在名单上。</p>
<p>虽然 Onto Innovation 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得投资。</p>
<p>在这里查看这五只股票</p>

ONTO

NNDM

<p>MarketBeat 确定了五只值得关注的纳米技术股票：Onto Innovation、Nano Dimension、NVE 和 Clene。这些公司致力于开发基于纳米尺度材料的产品，被视为投机性增长股。它们涵盖了医疗保健和电子等多个行业，并以其波动性而闻名。Onto Innovation 专注于光学计量工具，Nano Dimension 专注于增材制造，NVE 开发自旋电子设备，而 Clene 是一家处于临床阶段的制药公司，专注于纳米技术治疗</p>

<ul>
<li>3 Chip Stocks Approaching Buy Points</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只接近买入点的芯片股票</li>
</ul>
</div><p>Onto Innovation, Nano Dimension, NVE, and Clene are the five Nanotechnology stocks to watch today, according to MarketBeat's stock screener tool. Nanotechnology stocks are shares of companies that develop, manufacture, or commercialize products and services based on nanoscale materials, devices, or processes. For investors they are often viewed as speculative growth plays whose value depends on long-term scientific progress, commercialization and regulatory approval. These companies can span sectors such as healthcare, electronics, energy and advanced materials, and tend to be more volatile due to technical and market uncertainties. These companies had the highest dollar trading volume of any Nanotechnology stocks within the last several days.</p>
<div class="lb-trans"><p>根据 MarketBeat 的股票筛选工具，Onto Innovation、Nano Dimension、NVE 和 Clene 是今天值得关注的五只纳米技术股票。纳米技术股票是指那些开发、制造或商业化基于纳米材料、设备或工艺的产品和服务的公司的股票。对于投资者而言，这些股票通常被视为投机性增长投资，其价值依赖于长期的科学进展、商业化和监管批准。这些公司可以跨越医疗保健、电子、能源和先进材料等多个行业，由于技术和市场的不确定性，往往更加波动。这些公司在过去几天内的纳米技术股票中交易量最高。</p>
</div><p>Get <strong>Onto Innovation</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Onto Innovation</strong> 的提醒：</p>
</div><h2>Onto Innovation (ONTO)</h2>
<div class="lb-trans"><h2>Onto Innovation (ONTO)</h2>
</div><p>Onto Innovation Inc. engages in the design, development, manufacture, and support of process control tools that performs optical metrology. The company offers lithography systems and process control analytical software. It also offers process and yield management solutions, and device packaging and test facilities through standalone systems for optical metrology, macro-defect inspection, packaging lithography, and transparent and opaque thin film measurements.</p>
<div class="lb-trans"><p>Onto Innovation Inc.从事光学计量过程控制工具的设计、开发、制造和支持。该公司提供光刻系统和过程控制分析软件。它还通过独立系统提供过程和产量管理解决方案，以及光学计量、宏观缺陷检测、包装光刻和透明及不透明薄膜测量的设备包装和测试设施。</p>
</div><p>Read Our Latest Research Report on ONTO</p>
<div class="lb-trans"><p>阅读我们关于 ONTO 的最新研究报告</p>
</div><h2>Nano Dimension (NNDM)</h2>
<div class="lb-trans"><h2>Nano Dimension (NNDM)</h2>
</div><p>Nano Dimension Ltd., together with its subsidiaries, engages in additive manufacturing solutions in Israel and internationally. The company offers 3D printers, comprising AME systems, which are inkjet printers, that produces Hi-PEDs by depositing proprietary conductive and dielectric substances, as well as integrates in-situ capacitors, antennas, coils, transformers, and electromechanical components; micro additive manufacturing systems, a digital light processing printers (DLP) that achieves production-grade polymer and composite parts; and industrial additive manufacturing systems, that utilizes a patented foil system that fabricates ceramic and metal parts.</p>
<div class="lb-trans"><p>Nano Dimension Ltd.及其子公司在以色列和国际上从事增材制造解决方案。该公司提供 3D 打印机，包括 AME 系统，这是一种喷墨打印机，通过沉积专有的导电和绝缘物质来生产 Hi-PEDs，并集成原位电容器、天线、线圈、变压器和机电组件；微增材制造系统，一种数字光处理打印机（DLP），可实现生产级聚合物和复合材料零件；以及工业增材制造系统，利用专利箔系统制造陶瓷和金属零件。</p>
</div><p>Read Our Latest Research Report on NNDM</p>
<div class="lb-trans"><p>阅读我们关于 NNDM 的最新研究报告</p>
</div><h2>NVE (NVEC)</h2>
<div class="lb-trans"><h2>NVE (NVEC)</h2>
</div><p>NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data.</p>
<div class="lb-trans"><p>NVE Corporation 开发和销售使用自旋电子学的设备，这是一种依赖电子自旋来获取、存储和传输信息的纳米技术。该公司制造自旋电子产品，包括用于获取和传输数据的传感器和耦合器。</p>
</div><p>Read Our Latest Research Report on NVEC</p>
<div class="lb-trans"><p>阅读我们关于 NVEC 的最新研究报告</p>
</div><h2>Clene (CLNN)</h2>
<div class="lb-trans"><h2>Clene (CLNN)</h2>
</div><p>Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases.</p>
<div class="lb-trans"><p>Clene Inc.是一家临床阶段的制药公司，专注于新型清洁表面纳米技术（CSN）治疗药物的发现、开发和商业化。其主要药物候选者是 CNM-Au8，目前正在进行多项临床试验，包括一项已完成的第二阶段平台试验，以评估 CNM-Au8 在肌萎缩侧索硬化症（ALS）患者中的安全性和有效性；已完成的第二阶段概念验证临床试验，针对早期症状性 ALS 患者；已完成的两项开放标签研究者盲法第二阶段临床试验，研究大脑能量代谢物；已完成的第二阶段临床试验，治疗慢性视神经病变中的视觉通路缺陷以促进再髓鞘化；以及第二项第二阶段临床试验，治疗帕金森病患者。</p>
</div><p>Read Our Latest Research Report on CLNN</p>
<div class="lb-trans"><p>阅读我们关于 CLNN 的最新研究报告</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>MarketBeat's Top Five Stocks to Own in January 2026</li>
<li>3 Stocks Where Insiders Are Buying, Not Bailing</li>
<li>These 3 Underrated ETFs Could Boom in 2026</li>
<li>NVIDIA’s Next Leg Higher May Have Started at CES</li>
<li>MarketBeat Week in Review – 01/05 - 01/09</li>
<li>Warner Bros. Rejects Paramount's Offer—How It Affects WBD, NFLX, PSKY</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 在 2026 年 1 月的五大股票推荐</li>
<li>3 只内部人士正在买入而非抛售的股票</li>
<li>这 3 只被低估的 ETF 可能在 2026 年大幅上涨</li>
<li>NVIDIA 的下一轮上涨可能在 CES 上开始</li>
<li>MarketBeat 周报 – 01/05 - 01/09</li>
<li>华纳兄弟拒绝派拉蒙的报价——这对 WBD、NFLX、PSKY 的影响</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Onto Innovation Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 到 Onto Innovation 吗？</h2>
</div><p>Before you consider Onto Innovation, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Onto Innovation 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Onto Innovation wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即买入……而 Onto Innovation 并不在名单上。</p>
</div><p>While Onto Innovation currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Onto Innovation 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得投资。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

1 月 10 日值得关注的最佳纳米技术股票